Occudo Quantitative Strategies LP Allogene Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $208,980 - $349,920	-20,250 Reduced 29.52%	48,340 $522,000
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $241,320 - $437,082	-35,593 Reduced 34.16%	68,590 $782,000
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $796,999 - $1.59 Million	104,183 New	104,183 $949,000
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $347,649 - $525,989	-13,480 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $340,235 - $585,706	13,480 New	13,480 $340,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.